SITC 2026: UT MD Anderson Highlights Advances in Cancer Immunotherapy
· newswise.com · popularity 18/100 · 0 similar stories today · Cancer & Oncology (Health & Life Sciences)
Read the original at newswise.com →
Summary
Researchers from The University of Texas MD Anderson Cancer Center highlighted promising advances in cancer immunotherapy at the 2026 Society for Immunotherapy of Cancer (SITC) Annual Meeting. The presentations showcased early-phase clinical trials and preclinical studies exploring new approaches to treating advanced cancers, including solid tumors, brain cancer and melanoma. These studies offer new insights to improve the effectiveness of immunotherapies and expand treatment options for patients.
Found in: Newswise. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 12.